Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NEULAND LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
ADCOCK INGRAM
Jun-14
NEULAND LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,004320-   
Low Rs966231-   
Sales per share (Unadj.) Rs928.495.3-  
Earnings per share (Unadj.) Rs127.4-24.0-  
Cash flow per share (Unadj.) Rs168.6-19.9-  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs774.874.8-  
Shares outstanding (eoy) m12.83168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.62.9 55.3%   
Avg P/E ratio x11.7-11.5 -101.5%  
P/CF ratio (eoy) x8.8-13.9 -63.6%  
Price / Book Value ratio x1.93.7 52.0%  
Dividend payout %7.80-   
Avg Mkt Cap Rs m19,05246,551 40.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,0182,922 69.1%   
Avg. sales/employee Rs Th03,747.7-  
Avg. wages/employee Rs Th0680.6-  
Avg. net profit/employee Rs Th0-944.3-  
INCOME DATA
Net Sales Rs m11,91216,089 74.0%  
Other income Rs m97113 86.5%   
Total revenues Rs m12,00916,201 74.1%   
Gross profit Rs m2,718-2,788 -97.5%  
Depreciation Rs m528694 76.0%   
Interest Rs m131436 30.0%   
Profit before tax Rs m2,157-3,806 -56.7%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m522238 219.6%   
Profit after tax Rs m1,635-4,054 -40.3%  
Gross profit margin %22.8-17.3 -131.7%  
Effective tax rate %24.2-6.2 -387.4%   
Net profit margin %13.7-25.2 -54.5%  
BALANCE SHEET DATA
Current assets Rs m7,60911,784 64.6%   
Current liabilities Rs m4,3906,630 66.2%   
Net working cap to sales %27.032.0 84.4%  
Current ratio x1.71.8 97.5%  
Inventory Days Days6111 5.7%  
Debtors Days Days1,109124 894.4%  
Net fixed assets Rs m8,1896,869 119.2%   
Share capital Rs m12975 172.7%   
"Free" reserves Rs m9,8120-   
Net worth Rs m9,94112,628 78.7%   
Long term debt Rs m7424,438 16.7%   
Total assets Rs m15,79823,855 66.2%  
Interest coverage x17.5-7.7 -226.5%   
Debt to equity ratio x0.10.4 21.3%  
Sales to assets ratio x0.80.7 111.8%   
Return on assets %11.2-15.2 -73.7%  
Return on equity %16.4-32.1 -51.2%  
Return on capital %21.4-19.8 -108.1%  
Exports to sales %73.50-   
Imports to sales %15.10-   
Net fx Rs m6,9460-   
CASH FLOW
From Operations Rs m2,3721,373 172.7%  
From Investments Rs m-615-422 145.8%  
From Financial Activity Rs m-1,3584,028 -33.7%  
Net Cashflow Rs m4034,979 8.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.42 Rs / ZAR

Compare NEULAND LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare NEULAND LABS With: SYNCOM FORMULATIONS  MEDICAMEN BI  GSK PHARMA  PARMAX PHARMA  SUPRIYA LIFESCIENCE   



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.